Finance News – Blueprint Medicines
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Ceo
Tariffs
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Bse
Etf
Stablecoin
Investment
Blockchain
Eth
Ipo
Index
Solana
Sec
Trade
Inflation
Earnings
Revenue
Interest Rates
Sensex
Token
Coinbase
Wall Street
Treasury
Nasdaq
Federal Reserve
Nse
China
Bse Sensex
Traders
Nifty
Sp 500
Gold
Investor
Profit
Tesla
Company
Economy
Swaps
Pce Inflation
Msp
Hey Mint
Offsets Market
Gmgn
Bvps
Crypto Bettors
Pharmaceutical Firm
Draft Papers
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jun 02, 2025
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.
Read Full Article →